Drug Discovery World

JULY 5, 2023

In this scientific Poster , just revealed at ISSCR 2023, you will discover: How precision reprogramming generates consistent, functional human microglia (ioMicroglia) from iPSCs in just 10 days Independent validation that ioMicroglia undergo phagocytosis of both E.

Production 52

Production In-Vitro Drugs 52

BioTech 365

OCTOBER 14, 2021

Announces Publication of In Vitro Test Results Assessing Betadine® Formulations Against Four Coronaviruses Avrio Health L.P. Announces Publication of In Vitro Test Results Assessing Betadine® Formulations Against Four Coronaviruses Betadine® antiseptic products have not been demonstrated to … Continue reading →

In-Vitro 40

In-Vitro Production 40

Roots Analysis

AUGUST 18, 2023

In order to fasten the discovery of innovative drugs and personalized medication, improved in vitro simulation of human biology and pathologies is required. In order to fasten the discovery of innovative drugs and personalized medication, improved in vitro simulation of human biology and pathologies is required.

Production 52

Production In-Vitro Branding Drugs 52

Drug Discovery World

AUGUST 22, 2023

Claire D’Abreau-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines. Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost. Complex generics comprise a diverse range of products.

Production 52

Production Bioequivalency In-Vivo In-Vitro 52

Drug Discovery World

MARCH 14, 2023

In vitro transcription, or IVT, is a complex reaction, requiring key components like an RNA polymerase, nucleotides, and a DNA template to make each mRNA. The post New listicle: Five tips on scaling up IVT for mRNA production appeared first on Drug Discovery World (DDW).

Production 52

Production RNA In-Vitro DNA 52

Camargo

FEBRUARY 16, 2021

The Camargo Blog is publishing a four-part blog series highlighting those designation programs available specifically for products with rare disease indications: Orphan Drug Designation (ODD), Rare Pediatric Disease Designation (RPDD), and Humanitarian Use Device (HUD) designation. Definition of a Rare Disease or Condition.

Production 130

Production Drugs Marketing In-Vitro 130

Camargo

MARCH 25, 2021

The Camargo Blog is publishing a four-part blog series highlighting those designation programs available specifically for products with rare disease indications : Orphan Drug Designation (ODD), Rare Pediatric Disease Designation (RPDD), and Humanitarian Use Device (HUD) designation.

Production 130

Production Drugs In-Vitro Containment 130

Camargo

FEBRUARY 10, 2021

Drug development is an extremely cumbersome process, requiring the testing of an agent from in vitro studies to in vivo studies to in silico modeling. Given that it can take up to 20 years for a final product to be approved, it is unsurprising that drug attrition rates are very high. Approaches to Pharmacokinetic Analysis.

Production 133

Production Bioavailability In-Vivo Bioequivalency 133

Pharma Mirror

AUGUST 30, 2022

The testing facility, located in North Carolina, provides supportive technology at no cost allowing companies to test and prove their cell-based products at various stages of development. By eliminating the fluctuations and suboptimal transients caused by.

Medicine 130

Medicine In-Vitro Manufacturing Production 130

Druggist

OCTOBER 21, 2020

The main products used for toenail fungus treatment are available in most pharmacies, supermarkets and perhaps with the best range of products found online. Topical products, which are applied directly to the infected area, are the main products used as toenail fungus treatment.

Production 98

Production Containment In-Vitro Sales 98

Scienmag

SEPTEMBER 28, 2020

Credit: Bat-science.com New research by BAT indicates that modern oral products (MOPs) showed lower toxicity responses in certain assays than traditional cigarettes. Scientists analysed the toxicological impact of one of BAT’s nicotine pouch products, formerly called Lyft and now known as Velo, in an in vitro laboratory-based test.

Production 52

Production In-Vitro Scientist Research 52

Pharmaceutical Technology

SEPTEMBER 19, 2022

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorisation for AstraZeneca ’s Evusheld (formerly AZD7442) for Covid-19 in the European Union (EU). The combination therapy was also found to retain in vitro neutralisation of SARS-CoV-2 virus’ Omicron BA.5

In-Vitro 279

In-Vitro Antibody Vaccination Vaccine 279

XTalks

APRIL 14, 2022

Conventional in vitro and in vivo studies are used in the drug development pipeline. However, could there be another way for developing biomedical products using in silico technology? Therefore, companies can evaluate their drug candidates or medical device products in “virtual patients” before assessing them in humans.

Trials 98

Trials In-Vivo In-Vitro Clinical Trials 98

Roots Analysis

DECEMBER 12, 2022

In order to fasten the discovery of innovative drugs and personalized medication, improved in vitro simulation of human biology and pathologies is required. In order to fasten the discovery of innovative drugs and personalized medication, improved in vitro simulation of human biology and pathologies is required.

Production 40

Production In-Vitro Branding Marketing 40

Medical Xpress

JANUARY 26, 2023

The most promising technologies for production of in vitro models include 3D bioprinting. Bioengineered artificial skin has become an increasingly important and reliable platform for researchers to test the safety and efficacy of drugs and cosmetics. It can be produced on a large scale and is a good substitute for animal testing.

Cosmetics 75

Cosmetics In-Vitro Drugs Production 75

FDA Law Blog

FEBRUARY 19, 2024

Loloei tackled legal matters related to various aspects of the regulation of medical devices, in vitro diagnostics, and combination products including regulatory and compliance issues, dispute resolutions between the FDA and sponsors, and FDA enforcement actions. While at FDA, Ms. During her FDA tenure, Ms. Gibbs , HP&M Director.

In-Vitro 59

In-Vitro Engineer Production Regulation 59

Drug Discovery World

MARCH 22, 2023

Download this eBook to learn more about process development and manufacturing in the mRNA space to enable successful scale-ups of mRNA production for therapeutic applications.

Manufacturing 52

Manufacturing Development In-Vitro Vaccination 52

Pharmaceutical Technology

MAY 31, 2023

The company also offers in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. The company offers its products and services to hospitals, healthcare professionals, commercial laboratories, researchers, and pharmacists. ZNA-1041 is under clinical development by F. Buy the report here.

In-Vitro 130

In-Vitro Clinical Trials Clinical Trials Drugs 130

Drug Discovery World

MARCH 22, 2023

Download the eBook to learn more about process development and manufacturing in the mRNA space to enable successful scale-ups of mRNA production for therapeutic applications.

Manufacturing 52

Manufacturing Development In-Vitro Vaccination 52

Pharmaceutical Technology

JULY 15, 2022

Despite entering its fourth decade of availability, in vitro fertilization (IVF), a medical technique used to facilitate the conception of a baby for those facing fertility problems, remains an elusive dream for many. Fairtility also claims the product reduces the time taken for each IVF cycle by 30 hours. in 2000 to 12.3%

In-Vitro 264

In-Vitro Production Regulation Research 264

Drug Discovery World

AUGUST 9, 2022

Provider to the life sciences industry BioIVT has acquired enzymes manufacturer Cypex in a bid to enhance its product portfolio. . Based in Dundee, Cypex manufactures recombinant xenobiotic metabolizing enzymes with its product portfolio covering a wide range of proteins involved in drug metabolism. . This is a good match.

In-Vitro 52

In-Vitro Protein Production Bacteria 52

BioTech 365

AUGUST 13, 2020

BETADINE ANTISEPTIC PRODUCTS HAVE NOT BEEN DEMONSTRATED TO BE … Continue reading → .–(BUSINESS WIRE)–THIS RELEASE DISCUSSES INVESTIGATIONAL USES OF BETADINE AND IS NOT INTENDED TO CONVEY CONCLUSIONS ABOUT ITS EFFICACY OR SAFETY IN TREATING AND/OR PREVENTING COVID-19 OR ANY OTHER VIRUSES.

In-Vitro 40

In-Vitro Production 40

Scienmag

JULY 11, 2021

EGCG, a green tea polyphenol, as a modulator of in vitro methylglyoxal-induced Tau glycation and its impact on reducing advanced glycation end products in neuroblastoma cells Credit: Correspondence to – Subashchandrabose Chinnathambi – s.chinnathambi@ncl.res.in

In-Vitro 52

In-Vitro Production Medicine 52

Drug Discovery World

OCTOBER 2, 2023

Karikó and Weissman noticed that dendritic cells recognise in vitro transcribed mRNA as a foreign substance, which leads to their activation and the release of inflammatory signalling molecules. The effect was due to the reduced activation of an enzyme that regulates protein production. Image credit: Ill.

In-Vitro 65

In-Vitro Protein Vaccination Vaccine 65

Drug Discovery World

JANUARY 25, 2024

The research will include studies to assess the effects of Vaxxinity’s active immunotherapies on undisclosed proteins implicated with bone and muscle growth through in vitro and in vivo experiments, and animal models established by UCF.

Medicine 52

Medicine Research In-Vivo In-Vitro 52

FDA Law Blog

OCTOBER 24, 2023

It includes questions, text, logic, and prompts, and integrates databases such as FDA product codes and FDA-recognized voluntary consensus standards. There is also a third template for Pre-Submissions for Non-In Vitro and In Vitro Diagnostic devices.

In-Vitro 52

In-Vitro Regulation Production 52

Drug Discovery World

JANUARY 3, 2023

Under the terms of the agreement, Mersana will develop novel ADC product candidates against up to two targets utilising its Immunosynthen platform to conjugate proprietary antibodies from Merck KGaA, Darmstadt, Germany. . Mersana will receive an upfront payment of $30 million.

Antibody 52

Antibody Development Research Drugs 52

XTalks

JUNE 30, 2023

Sartorius is a globally recognized player in the diagnostics industry, providing a variety of solutions for in vitro diagnostics kit (IVD) manufacturers. She has been involved in various medical and IVD product developments, certifications and registrations, both internally and externally. Xu joined Sartorius in 2002.

In-Vitro 52

In-Vitro Manufacturing Production Antibody 52

FDA Law Blog

MARCH 31, 2024

A fundamental divide is over whether LDTs and in vitro diagnostic products (IVDs) should continue to be regulated differently or if legislation can be crafted and enacted that will cover both types of products. This seems to have been the outcome that many lawmakers desired. These are areas where “revenue is modest,” she said.

Regulation 64

Regulation In-Vitro Development Gene Therapy 64

BioTech 365

SEPTEMBER 14, 2020

– Lead product candidate, SB206 currently being evaluated in B-SIMPLE4 pivotal Phase 3 study in molluscum contagiosum with topline data targeted for Q2 2021 – – In vitro assessments of ability of NITRICIL™ to inhibit the replication mechanisms of SARS-COV-2 … Continue reading →

In-Vitro 40

In-Vitro Development Production 40

XTalks

JANUARY 29, 2024

Coloplast’s product portfolio includes Ostomy Care, Continence Care, Wound and Skin Care, Interventional Urology and Voice and Respiratory Care. Coloplast is determined to find the right balance between minimizing its environmental footprint and compromising the quality of its products.

Packaging 64

Packaging Packaging Production In-Vitro 64

Drug Discovery World

JANUARY 31, 2024

Support for danegapitide’s potential With safety data derived from over 500 clinical trial participants, robust toxicology data, and strong non-clinical in vitro and in vivo efficacy results, there is strong support for danegaptide’s potential to address the clinical core ocular pathologies of vascular leakage and capillary breakdown.

Clinical Trials 52

Clinical Trials Clinical Trials In-Vivo In-Vitro 52

Drug Discovery World

FEBRUARY 13, 2024

It has demonstrated efficacy in in vitro and in vivo models of fibrosis, as well as favourable safety and pharmacokinetic profiles in Phase I clinical studies. It has demonstrated efficacy in in vitro and in vivo models of fibrosis, as well as favourable safety and pharmacokinetic profiles in Phase I clinical studies.

Drugs 52

Drugs In-Vivo In-Vitro Medicine 52

Pharmaceutical Technology

JUNE 6, 2023

Pharma Mar offers in vitro diagnostic products used for detection of virus and bacteria in respiratory infections and human papilloma virus genotypes, among others. Ecubectedin is a small molecule commercialized by Pharma Mar, with a leading Phase II program in Hormone Sensitive Breast Cancer. Buy the model here. over FY2021.

Hormones 100

Hormones In-Vitro Genotype Bacteria 100

Pharmaceutical Technology

JUNE 5, 2023

The company also offers in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. The company offers its products and services to hospitals, healthcare professionals, commercial laboratories, researchers, and pharmacists. Pralsetinib is under clinical development by F. Buy the report here.

In-Vitro 100

In-Vitro Drugs Clinical Trials Clinical Trials 100

FDA Law Blog

SEPTEMBER 27, 2022

The program began accepting proposals on September 7, 2022, from manufacturers that have existing technologies and can scale production, while meeting FDA quality requirements. The focus of the program is for both molecular and antigen tests that can be used in either point-of-care settings or home use.

In-Vitro 59

In-Vitro Manufacturing Antibody Regulation 59

XTalks

JUNE 26, 2023

Medical device and in vitro diagnostics technologies provider SurModic Inc. Surmodics will manufacture and supply the device and realize revenue from product sales to Abbott as well as a share of profits from Abbott’s third-party sales. The balloon is designed for the treatment of patients with peripheral artery disease.

FDA Approval 96

FDA Approval Drugs Sales In-Vitro 96